A prospective study of the effects of oral probenecid on the pharmacokinetics of intravenous ticarcillin in patients with cystic fibrosis. 1992

L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean

UI MeSH Term Description Entries
D008297 Male Males
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013982 Ticarcillin An antibiotic derived from penicillin similar to CARBENICILLIN in action. BRL-2288,Tarcil,Ticar,Ticarcillin Disodium,Ticarpen,Ticillin,BRL 2288,BRL2288,Disodium, Ticarcillin

Related Publications

L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
January 1990, Clinical pharmacology and therapeutics,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
January 1991, Developmental pharmacology and therapeutics,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
May 1991, Zentralblatt fur Veterinarmedizin. Reihe A,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
June 1984, Pathologie-biologie,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
July 2011, Antimicrobial agents and chemotherapy,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
October 2011, The Journal of antimicrobial chemotherapy,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
June 1985, The Journal of pediatrics,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
December 1980, American journal of diseases of children (1960),
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
January 2024, Clinical therapeutics,
L Corvaia, and S C Li, and L L Ioannides-Demos, and G Bowes, and W J Spicer, and D W Spelman, and N Tong, and A J McLean
December 2003, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!